(Q34382793)

1 August 2017

1 reference

title

Macrolides: pharmacokinetics and pharmacodynamics (English)

1 reference

1 August 2017

1 reference

1 reference

Van Bambeke F

1 reference

1 August 2017

Tulkens PM

series ordinal

1 reference

1 August 2017

publication date

1 January 2001

1 reference

International Journal of Antimicrobial Agents

1 August 2017

published in

1 reference

1 August 2017

volume

18 Suppl 1

1 reference

1 August 2017

page(s)

S17-23

1 reference

Aminoglycosides: nephrotoxicity

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

High-dose intravenous fluoroquinolones in the treatment of severe infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Relevance of the Alexander Project: pharmacodynamic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

AUIC--the universal parameter within the constraint of a reasonable dosing interval

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Kinetics of antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Pharmacokinetics and pharmacodynamics of newer macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Postantibiotic effect of amikacin, rifampin, sparfloxacin, clofazimine and clarithromycin against Mycobacterium avium.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Bactericidal properties of moxifloxacin and post-antibiotic effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

The post-antibiotic sub-MIC effect in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Postantibiotic leukocyte enhancement: increased susceptibility of bacteria pretreated with antibiotics to activity of leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Impact of pH and cationic supplementation on in vitro postantibiotic effect

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Pulsed-exposure and postantibiotic leukocyte enhancement effects of amikacin, clarithromycin, clofazimine, and rifampin against intracellular Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Intracellular microorganisms: a particular problem for chemotherapy. Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Activity of antibiotics against microorganisms ingested by mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Lack of effective bactericidal activity of new quinolones against Brucella spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Levofloxacin penetrates human monocytes and enhances intracellular killing of Staphylococcus aureus and Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Antimicrobial resistance issues of the future

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

The future--can we learn from the past?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900406-X

7 January 2021

10.1016/S0924-8579(01)00406-X

Identifiers

DOI

1 reference

1 August 2017

1 reference